oasis-1 oral semaglutide 50 mg obesity nejm 2023 of #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj The FDA recently approved the

Food is Medicine 101 The Food is Medicine 101 continuing education course through University College aims to educate health professionals on the critical link between nutrition and health and its application to the healthcare setting

In the early stages of insulin resistance, your pancreas creates more insulin, increasing insulin levels

Restricting calories can lead to fatigue, making it more challenging to stay active and committed to exercise

The smaller injection volume means less liquid under the skin, which many people find more comfortable

Constipation is a common side effect of GLP-1 receptor agonists like Wegovy and Mounjaro

Final CME INDIA Take-Home ADA 2026 was dominated by oral incretins, triple agonists, weight-loss pharmacology, CGM beyond insulin, kidney protection beyond diabetes, lipid intensification after PCI, and early type 1 diabetes disease modification